New derivatives of isonicotinic acid hydraside as potential antitubercular agents

N. B. Goncharenko, V. V. Blagodatnyi, V. V. Kovalishyn, І. M. Kopernyk, O. P. Kozachenko, V. S. Brovarets, L. О. Metelytsia

Abstract


The appearance of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) is a stimulus for searching new and efficient antitubercular drugs. Despite the appearance of new antitubercular drugs, isoniazid is still the key and most effective component in all multitherapeutic regimens recommended by the WHO. This paper describes the QSAR design, synthesis and in vitro evaluation of the antitubercular activity of several potent isoniazid derivatives against Mtb strain (H37Rv) and resistant strain (HR). The QSAR method was applied using Artificial Neural Networks. The predictive ability of the regression model was estimated through leave-one-out cross-validation coefficient q2. The inhibition activities of 440 virtual compounds against Mtb were evaluated by the QSAR model developed, and seven isoniazid derivatives were selected and synthesized. In the biological research the multidrug-resistant strain of Mtb with resistance to isoniazid and rifampicin was used. All compounds synthesized with the predicted high activity showed antimycobacterial activity against Mtb strain H37Rv. “The compound-leader” – N1-(3-nitrophenylmethylidene)-pyridine-4-karbohidrazide revealing the activity against multiresistant strain (HR) of Mtb is identified as an original object for further research as an potential antimycobacterial agent.

Keywords


QSAR; Mycobacterium tuberculosis; H37RV; HR; isoniazide derivatives

References


Petrenko V. M. Ukrayns`kyj Pul`monologichnyj zhurnal – Ukrainian Pulmonology Journal, 2007, No.3, pp.35-39.

World Health Organization. Global Tuberculosis Control: WHO Report 2012, Geneva: World Health Organization, WHO/CDS/CPC/TB/99.259.

Panin I. V., Dobin V. L., Kochetkova G. V., Zamurueva E. V. Mezhdisciplinarnye aspectydifferencial`noj diagnostiki s lechenija bol`nyh tuberculezom, 2012, pp.54-55.

Cubillos-Ruiz A., Morales J., Zambrano M. M. Bio. Med. Central. Research Notes, 2008, doi:10.1186/1756-0500-1-110.

Levyc`ka N. A., Bajora Y. I.,Nikolaevs`kyj V. V., Asmolov O. K. Ukrayns`kyj Pul`monologichnyj zhurnal – Ukrainian Pulmonology Journal, 2003, No.4, pp.17-19.

Ostroverha Y. A, Berenazhna L. V., Koval` J. B., Lozyns`ka H. R., Romanec` O. M. Profilaktyka tuberkul`ozu. Metodychnyj posibnyk. L`viv, 2012, p.168.

Strachunskij L. S., Belousov Y. B., Kozlov C. N. Prakticheskoe rukovodstvo po nfekcionnoj himioterapii. Smolensk, 2002, p.586.

Kovalishyn V., Kopernyk I., Chumachenko S., Shablykin O., Kondratyuk K., Pil’o S., Prokopenko V., Brovarets V., Metelytsia L. Computational Biology and Bioinformatics, 2014, Vol. 2, No.2, pp.25-32.

Kovalishyn V., De Sousa J. A., Ventura C., Leitao R. E., Martins F. Chemometrics and Intelligent Laboratory Systems, 2011, Vol. 107, pp.69-74.

https://www.chemaxon.com/, (accessed in January, 2014).

http://www.talete.mi.it/products/dragon_description.htm (accessed in March 2014).

Tetko I. V. J. Chem. Inf. Comput. Sci. Vol., 2002, No.42, pp.717-728.

Kovalishyn V., Tanchuk V., Charochkina L., Semenuta I., Prokopenko V. Journal of Molecular Graphics and Modeling, 2012, Vol. 32, pp.32-38.

Tetko I. V., Villa A. E. P. Neural Networks, 1997, No.10, pp.1361-1374.

Cramer R. D., Patterson D. E., Bunce J. D. J. Am. Chem. Soc., 1988, Vol. 110, No.18, pp.5959-5967.

Tropsha A. Mol. Inf., 2010, No.29, pp.476-488.

Tetko I. V., Villa A. E. P., Aksenova T. I. et al. J. Chem. Inf. Comput. Sci., 1998, Vol. 38, pp.676-684.

Kovalishyn V. V., Tetko I. V., Luik A. I., Kholodovych V. V., Villa A. E. P., Livingstone D. J. J. Chem. Inf. Comp. Sci., 1998, No.38, pp.651-659.

Lo Monte F., Kramer T., Gu J., Brodrecht M., Pilakowski J., Fuertes A., Dominguez J.M., Plotkin B., Eldar-Finkelman H., Schmidt B. European Journal of Medicinal Chemistry, 2013, Vol. 61, pp.26-40.

Rao V. S., Chandra Sekhar K. V. G. Synthetic Communications, 2004, Vol. 34, No.12, pp.2153-2157.

Martins F., Santos S., Ventura C., Elvas-Leitao R., Santos L., Vitorino S., ReisM., Miranda V., Correia H., Aires-De-Sousa J., Kovalishyn V., Latino D., Ramos J., Viveiros M. European Journal of Medicinal Chemistry, 2014, Vol. 81, pp.119-138.

Sah, Peoples. Journal of the American Pharmaceutical Association, 1954, Vol. 43, pp.513-514.

Todoriko L. D., Eremenchuk I. V., Chornous V. O., Grozav A. M. Pul`monologichnyj zhurnal – Ukrainian Pulmonology Journal, 2012, No.1, pp.8-12.

Rafiq Y., Jabeen K., Hasan R. PLOS ONE Journal Information, 2012, doi:10.1371/journal.pone.0050551, http://www.plosone.org/


GOST Style Citations






DOI: https://doi.org/10.24959/ophcj.15.831

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Ž. org. farm. hìm.

ISSN 2518-1548 (Online), ISSN 2308-8303 (Print)